Danaher SVP Sells 20K Shares and 4 Insider Sales to Note

Raskas Daniel who is SVP-Corporate Development at Danaher Corp. (NYSE:DHR), sold 20,000 shares at $71.99 per share for a total value of $1,439,760. The shares recently traded at $71.93, down $0.06, or 0.08% since the insider sale.

dhr-20131022

Sheedy William M. who is GBL EXEC CORP STR, M&A and GR at Visa, Inc. (NYSE:V), sold 8,500 shares at $197.81 per share for a total value of $1,681,385. The shares recently traded at $200.04, up $2.23, or 1.13% since the insider sale.

v-20131022

Jeffs Roger who is President & COO at United Therapeutics Corp. (NASDAQ:UTHR), sold 10,000 shares at $82.47 per share for a total value of $824,700. The shares recently traded at $81.12, down $1.35, or 1.64% since the insider sale.

uthr-20131022

Slovin Bruce who is Director at Cantel Medical Corp. (NYSE:CMN), sold 20,000 shares at $34.98 per share for a total value of $699,648. The shares recently traded at $34.68, down $0.3, or 0.86% since the insider sale.

cmn-20131022

Ambroseo John who is Pres. and CEO at Coherent Inc. (NASDAQ:COHR), sold 11,183 shares at $66.07 per share for a total value of $738,901. The shares recently traded at $65.56, down $0.51, or 0.77% since the insider sale.

cohr-20131022

Don’t Miss: Researcher: Verizon Security Glitch Left Customer Information Vulnerable.